Lineage Cell Therapeutics
LCTX
#8906
Rank
C$0.27 B
Marketcap
C$1.11
Share price
-5.87%
Change (1 day)
-54.89%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2026 (TTM): C-$0.37

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.39. In 2019 the company made an earnings per share (EPS) of C-$0.05736 an increase over its 2018 EPS that were of C-$0.50.

EPS history for Lineage Cell Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.37
2019C-$0.05736-88.57%
2018C-$0.50
2016C$0.46
2014C-$0.80
2012C-$0.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA